KIRSTEN SCHWAB: Open Payments
NPI 1063722486 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 86 payments from 12 companies in 2025. Trend: 2023 $721 · 2024 $1,260 · 2025 $1,675
Food & beverage: $1,510Education: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $448 |
| GENZYME CORPORATION | 13 | $264 |
| LEO Pharma Inc. | 7 | $172 |
| Janssen Biotech, Inc. | 10 | $170 |
| UCB, Inc. | 10 | $157 |
| Novartis Pharmaceuticals Corporation | 8 | $155 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Lilly USA, LLC | 3 | $69 |
| Botanix SB Inc | 3 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $43 |
Products named: DUPIXENT, ADBRY, TREMFYA, BOTOX, Bimzelx, SKYRIZI, COSENTYX, TALTZ.
Industry payments across CA — which companies pay providers there.
